초록 ▼

An apparatus for performing in-vivo sonoporation of a skin area and transdermal and/or intradermal delivery of a drug solution includes a container having an end adjacent the skin area and containing the drug solution. The container further includes an ultrasound horn having a tip submerged in the d

An apparatus for performing in-vivo sonoporation of a skin area and transdermal and/or intradermal delivery of a drug solution includes a container having an end adjacent the skin area and containing the drug solution. The container further includes an ultrasound horn having a tip submerged in the drug solution for applying ultrasound radiation to the drug solution. The ultrasound radiation has a frequency in the range of 15 KHz and 1 MHz and is applied at an intensity, for a period of time and at a distance from said skin area effective to generate cavitation bubbles. The cavitation bubbles collapse and transfer their energy into the skin area, thus causing the formation of pores in the skin area. The ultrasound radiation intensity and distance from the skin area are also effective in generating ultrasonic jets, which ultrasonic jets then drive the drug solution through the end adjacent the skin area and the formed pores into the skin.

대표청구항 ▼

1. An apparatus for performing in-vivo sonoporation of skin area and transdermal and/or intradermal delivery of a drug solution comprising: an ultrasound horn having a tip submerged in said drug solution and applying ultrasound radiation to said drug solution wherein said ultrasound radiation has a

1. An apparatus for performing in-vivo sonoporation of skin area and transdermal and/or intradermal delivery of a drug solution comprising: an ultrasound horn having a tip submerged in said drug solution and applying ultrasound radiation to said drug solution wherein said ultrasound radiation has a frequency in the range of 15 KHz and 1 MHz and is applied at an intensity, for a period of time and at a distance from said skin area effective to generate cavitation bubbles, wherein said cavitation bubbles collapse and transfer their energy into the skin area thus causing the formation of pores in the skin area; and wherein said ultrasound radiation intensity and distance from the skin area are also effective in generating ultrasonic jets, said ultrasonic jets driving said drug solution transdermally through said formed pores into the skin area.2. The apparatus of 1 wherein said formed pores have a diameter in the range of 1 micrometer to 100 micrometers.3. The apparatus of 1 wherein said tip is removably connected to said ultrasound horn.4. The apparatus of 1 wherein said tip comprises a flat distal end surface.5. The apparatus of 1 wherein said tip comprises a concave distal end surface.6. The apparatus of claim 1 wherein said tip comprises a distal end surface having a plurality of depressions.7. The apparatus of claim 1 wherein said tip comprises a body having markings indicating the amount of the drug solution contained in the container.8. The apparatus of claim 1 further comprising a container which comprises: an outer wall; an inner wall; and an absorbent wick placed between said inner and outer wall, said wick absorbing any excess drug solution that is not driven into the skin area through the formed pores.9. The apparatus of 8 wherein said wick comprises a spongy material having highly absorbent and hydrophilic properties.10. The apparatus of 8 wherein said wick comprises a highly absorbent and hydrophilic material selected from the group consisting of absorbent cellulose material, polyvinyl alcohol sponge, sodium carboxy-methyl cellulose, and blotting paper.11. The apparatus of 8 wherein said inner wall comprises first and second grooves, said tip comprises a body having first and second grooves and wherein said first and second grooves of the tip body are arranged opposite said first and second grooves of the container inner wall, the arrangement defining first and second spaces for accommodating first and second o-rings, respectively.12. The apparatus of 8 wherein said container further comprises an inlet septum for filling said container with the solution.13. The apparatus of claim 8 wherein said container is a cylinder.14. The apparatus of claim 8 wherein said container comprises a transparent material.15. The apparatus of claim 8 wherein said container comprises a plastic material.16. The apparatus of claim 1 wherein said ultrasound frequency is 20 KHz.17. The apparatus of claim 1 wherein said ultrasound intensity is in the range of 5 W/cm2 and 55 W/cm2.18. The apparatus of claim 1 wherein said tip has a distal end located at a distance from said skin area in the range of 1 millimeter to 10 millimeters.19. The apparatus of claim 1 wherein said ultrasound radiation is continuous.20. The apparatus of claim 1 wherein said ultrasound radiation is pulsed.21. The apparatus of claim 1 wherein said period of time is in the range of about 30 seconds to 5 minutes of continuous exposure to said ultrasound radiation.22. The apparatus of claim 1 wherein said period of time is in the range of about 10 minutes to 20 minutes of pulsed exposure to said ultrasound radiation with a 5% duty cycle.23. The apparatus of claim 1 further comprising a container having an end covered with a membrane at the skin area and containing said drug solution, wherein said membrane is hydrophobic.24. A method of performing in-vivo sonoporation of a skin area and transdermal and/or intradermal delivery of a drug solution comprising: providing a container containing a predetermined amount of said drug solution; submerging a tip of an ultrasound horn in said drug solution through said container; placing said container in contact with said skin area; and applying ultrasound radiation to said drug solution wherein said ultrasound radiation has a frequency in the range of 15 KHz and 1 MHz and is applied at an intensity, for a period of time and at a distance from said skin area effective to generate cavitation bubbles, wherein said cavitation bubbles collapse and transfer their energy into the skin area thus causing the formation of pores in the skin area; and wherein said ultrasound radiation intensity and distance from the skin area are also effective in generating ultrasonic jets, said ultrasonic jets driving said drug solution transdermally through said formed pores into the skin area.25. The method of claim 24 wherein said tip is removably connected to said ultrasound horn comprising before submerging said tip in said drug solution attaching said tip to said ultrasound horn.26. The method of claim 25 further comprising sterilizing said tip before attaching it to said ultrasound horn.27. The method of claim 24 wherein said tip comprises a flat distal end surface.28. The method of claim 24 wherein said tip comprises a concave distal end surface.29. The method of claim 24 wherein said tip comprises a distal end surface having a plurality of depressions.30. The method of claim 24 wherein said tip comprises a body having markings indicating the amount of the drug solution contained in the container.31. The method of claim 30 further comprising checking the amount of said drug solution contained in the container before applying said ultrasound radiation.32. The method of claim 31 further comprising adding drug solution to said container.33. The method of claim 24 wherein said container comprises: an outer wall; an inner wall; and an absorbent wick placed between said inner and outer wall, said wick absorbing any excess drug solution that is not driven into the skin area through the formed pores.34. The method of claim 24 wherein said ultrasound frequency is 20 KHz.35. The method of claim 24 wherein said ultrasound intensity is in the range of 5 W/cm2 and 55 W/cm2.36. The method of claim 24 wherein said tip has a distal end located at a distance from said skin area in the range of 1 millimeter to 10 millimeters.37. The method of claim 24 wherein said ultrasound radiation is continuous.38. The method of claim 24 wherein said ultrasound radiation is pulsed.39. The method of claim 24 wherein said period of time is in the range of about 30 seconds to 5 minutes of continuous exposure to said ultrasound radiation.40. The method of claim 24 wherein said period of time is in the range of about 10 minutes to 20 minutes of pulsed exposure to said ultrasound radiation with a 5% duty cycle.41. The method of claim 24 wherein said formed pores have a diameter in the range of 1 micrometer to 100 micrometers.42. The method of claim 24 wherein, said the container comprising a hydrophobic membrane adjacent to the skin area.